Blonder Tongue Laboratories, Inc.

    Blonder Tongue Laboratories, Inc.

    OOTC:BDRL
    0.02
    USD
    -0.01
    (-22.73%)
    Blonder Tongue Laboratories, Inc.
    OTC:BDRL
    (OTC Markets)

    Recent

    price

    0.02

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    USD
    4.69
    4.93
    4.29
    4.93
    4.48
    4.68
    3.24
    3.04
    2.84
    2.44
    2.07
    1.65
    1.3
    1.36
    0.94
    0.77
    0.81
    Revenue per Share
    0.01
    0.29
    -0.07
    -0.83
    -0.45
    -0.14
    -1.05
    -0.16
    -0.05
    -0.15
    -0.08
    -0.76
    0.01
    -0.22
    -0.15
    -0.09
    -0.08
    Basic EPS, GAAP
    -0.25
    0.33
    -0.07
    -0.64
    0.16
    0.17
    -0.19
    0.1
    -0.04
    0.06
    -0.69
    -0.33
    -0.1
    -0.11
    0.1
    0.07
    0.11
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    0.55
    0.84
    0.77
    -0.06
    -0.51
    -0.66
    -1.89
    -2.32
    -2.18
    -2.15
    -2.07
    -2.77
    -2.25
    -2.28
    -2.31
    -2.33
    -2.26
    Book Value per Share
    3.22
    3.44
    3.31
    2.11
    1.85
    1.71
    0.72
    0.58
    0.67
    0.61
    0.6
    -0.02
    0.17
    -0.01
    -0.13
    -0.21
    -0.14
    Tangible Book Value per Share
    6
    6
    6
    6
    6
    6
    6
    7
    8
    9
    10
    10
    12
    13
    14
    14
    14
    Basic Weighted Avg Shares
    29
    31
    27
    31
    28
    29
    21
    23
    23
    22
    20
    16
    16
    18
    13
    11
    12
    Sales/Revenue/Turnover
    0.7
    6.48
    -0.88
    -8.14
    -9.13
    -2.16
    -30.56
    -2.98
    1.99
    -3.93
    -38.51
    -43.43
    -18.79
    -11.76
    -9.52
    -6.11
    -5.66
    Operating Margin (%)
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    Depreciation Expense
    - -
    2
    - -
    -5
    -3
    -1
    -7
    -1
    - -
    -1
    -1
    -7
    - -
    -3
    -2
    -1
    -1
    Net Income, GAAP
    178.57
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    15.15
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    0.26
    5.85
    -1.54
    -16.83
    -10.13
    -3.1
    -32.33
    -5.31
    -1.65
    -6.17
    -3.74
    -45.63
    0.53
    -16.12
    -16.02
    -11.18
    -10.49
    Profit Margin (%)
    11
    12
    12
    10
    9
    9
    - -
    3
    5
    2
    4
    1
    2
    - -
    -2
    -3
    -2
    Working Capital
    3
    3
    3
    4
    4
    4
    - -
    4
    4
    - -
    3
    4
    3
    6
    5
    5
    5
    LT Debt
    20
    22
    21
    17
    15
    14
    7
    7
    7
    7
    7
    1
    3
    1
    -1
    -2
    -1
    Total Equity
    -0.68
    8.14
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -29.11
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    -0.93
    26.41
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -2.51
    - -
    - -
    - -
    - -
    Return on Capital (%)
    2.22
    41.4
    -8.22
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    4
    4
    3
    LT Borrowings
    2
    2
    2
    LT Finance Leases
    3
    3
    3
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    14
    14
    14
    Market Capitalization
    1
    1
    1

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    5
    5
    5
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    2
    2
    2
    Inventories
    3
    3
    3
    Total Current Liabilities
    6
    7
    6
    Payables & Accruals
    2
    3
    3
    ST Debt
    4
    4
    3
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    5.14%
    19.24%
    229.96%
    Free Cash Flow
    -238.22%
    -62.47%
    -23.4%
    Net Income, GAAP
    -213.4%
    -567.72%
    -41.05%
    Sales/Revenue/Turnover
    -8.14%
    -9.77%
    -15.5%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    4
    3
    3
    3
    13
    2024
    3
    3
    - -
    - -
    11
    2025
    3
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.04
    -0.05
    -0.02
    - -
    -0.15
    2024
    -0.02
    -0.01
    - -
    - -
    -0.09
    2025
    -0.02
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • accessnewswire.com

      Blonder Tongue Expands NTSC Line with Launch of CV NTSC32 IP Digital-to-Analog Synthesizer

    • accesswire.com

      NAGRAVISION and Blonder Tongue Partner to Secure Next-Generation Content Distribution for Hospitality Venues Across North America

    • accesswire.com

      Blonder Tongue Announces Extensive 20 Year Service Offering for NXG Video Delivery System

    • seekingalpha.com

      Blonder Tongue Laboratories, Inc. (BDRL) Q3 2022 Earnings Call Transcript

    • accesswire.com

      Blonder Tongue Schedules Conference Call to Discuss Third Quarter 2022 Earnings Results

    • seekingalpha.com

      Blonder Tongue Laboratories, Inc. (BDRL) CEO Ted Grauch on Q2 2022 Results - Earnings Call Transcript